On the use of intravenous metronidazole for severe and complicated

Clostridioides difficile Metronidazole oral vancomycin

Journal

Le infezioni in medicina
ISSN: 2532-8689
Titre abrégé: Infez Med
Pays: Italy
ID NLM: 9613961

Informations de publication

Date de publication:
2024
Historique:
received: 28 09 2023
accepted: 10 01 2024
medline: 8 3 2024
pubmed: 8 3 2024
entrez: 8 3 2024
Statut: epublish

Résumé

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) has advised against the use of metronidazole for fulminant

Identifiants

DOI: 10.53854/liim-3201-3 PMID: 38456021 PMC: PMC10917561
pubmed: 38456021
doi: 10.53854/liim-3201-3
pii: 1124-9390_32_1_2024_020-024
pmc: PMC10917561
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

20-24

Déclaration de conflit d'intérêts

Conflict of interest: Authors declare no conflict of interest.

Auteurs

Giuseppe Pipitone (G)

Infectious Disease Unit, ARNAS Civico-Di Cristina, Palermo, Italy.

Guido Granata (G)

Clinical and Research Department for Infectious Diseases, INMI Lazzaro Spallanzani IRCCS.

Massimo Sartelli (M)

Department of Surgery, Macerata Civil Hospital, Macerata, Italy.

Andrea Gizzi (A)

Infectious Disease Unit, ARNAS Civico-Di Cristina, Palermo, Italy.
Infectious Disease Unit, University Hospital P. Giaccone, Palermo, Italy.

Claudia Imburgia (C)

Infectious Disease Unit, ARNAS Civico-Di Cristina, Palermo, Italy.

Laura Marsala (L)

Medical Direction Unit, ARNAS Civico-Di Cristina, Palermo, Italy.

Antonio Cascio (A)

Infectious Disease Unit, University Hospital P. Giaccone, Palermo, Italy.

Chiara Iaria (C)

Infectious Disease Unit, ARNAS Civico-Di Cristina, Palermo, Italy.

Classifications MeSH